Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 136Unknown 40Recruiting 34Terminated 28Active not recruiting 20Withdrawn 10Not yet recruiting 10Enrolling by invitation 4Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Neoplasms 73Breast Neoplasms 70Colorectal Neoplasms 39Prostatic Neoplasms 37Carcinoma, Non-Small-Cell Lung 26Lung Neoplasms 25Stomach Neoplasms 20Carcinoma, Hepatocellular 20Uterine Cervical Neoplasms 19Pancreatic Neoplasms 15Anxiety Disorders 15Leukemia, Myeloid, Acute 14Hematologic Neoplasms 13Colonic Neoplasms 13Brain Neoplasms 13Urinary Bladder Neoplasms 12Lymphoma, Follicular 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Head and Neck Neoplasms 11Esophageal Neoplasms 10Diabetes Mellitus 10Ovarian Neoplasms 9Melanoma 9Liver Neoplasms 9Sarcoma 8Rectal Neoplasms 8Pulmonary Disease, Chronic Obstructive 8Multiple Myeloma 8Esophageal Squamous Cell Carcinoma 8Disease 8

Interventions

130-nm albumin-bound paclitaxel 2camrelizumab 1anlotinib 1S 1 (combination) 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Gallbladder Neoplasms × Clear all
NCT07310069 2025-12-30

TRANSFORM-GBC

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Enrolling by invitation
44 enrolled
Gastrointestinal

Gallbladder Neoplasms

NCT06963060 2025-05-08

GALENT-BT

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Enrolling by invitation
44 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT06901622 2025-03-30

Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic Cholangiocarcinoma

The First Affiliated Hospital of Zhengzhou University

Phase 2 Enrolling by invitation
50 enrolled
Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma

NCT06671418 2024-11-04

TESLA RCT

Erasmus Medical Center

Phase 3 Enrolling by invitation
148 enrolled
Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡